UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 7, 2022
Accession Number:
0001104659-22-032698
Submission Type:
POS AM
CIK:
0001720893
Company Name:
BioXcel Therapeutics, Inc.
File Number:
333-240118